Skip to content
Bending the Curve Trial by Trial
?

First author of the 1991 and 1995 papers on ICI D1694 and ZD1694 (raltitrexed)

A. L. Jackman

First author listed in PubMed for a 1991 Cancer Research paper describing ICI D1694 as a quinazoline antifolate thymidylate synthase inhibitor for clinical study, and for a 1995 European Journal of Cancer paper on ZD1694 (Tomudex).

Sources

  1. Jackman AL, Taylor GA, Gibson W, Kimbell R, Brown M, Calvert AH, et al. ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study. Cancer Res. 1991;51(20):5579-86.

    PubMed

  2. Jackman AL, Farrugia DC, Gibson W, Kimbell R, Harrap KR, Stephens TC, et al. ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancer. Eur J Cancer. 1995;31A(7-8):1277-82.

    PubMedDOI